Get the app
US › Healthcare

Carlsmed, Inc. (CARL)

US · Healthcare · Health Information Services

$13.41-3.87%
Last close · 2026-10-16

Latest quarter · ended 2026-06-30

Revenue
$18.9M
Revenue YoY
+56.7%
Net profit
$-10.5M
EPS
$-0.39
EPS estimate
$-0.40
Net margin
-55.5%

EPS came in at -0.39 against a street estimate of -0.40 — a beat of 2.5%.

Key statistics

Market cap
$395.1M
Forward P/E
0.0
P/B
4.79
Book value
$3.09
EPS (TTM)
$-1.08
52-week high
$17.23
52-week low
$8.50
50-day MA
$14.91
200-day MA
$12.30

Analyst view

Analysts rate Carlsmed, Inc. a strong buy (5 buy, 0 hold, 0 sell out of 5) with an average price target of $19.40.

Shareholding

Insiders
45.04%
Institutions
40.44%

Largest institutional holders

FundStake
Jupiter Topco LLC4.58%
HHG PLC4.50%
Parkman Healthcare Partners LLC2.19%
BlackRock Inc1.95%
KCM Capital Inc1.61%
Pier Capital, LLC1.37%
Millennium Management LLC1.08%
Palumbo Wealth Management LLC0.98%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Carlsmed, Inc. — free to start.

Open in the appGoogle PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncAmgen IncGilead Sciences IncAbbott LaboratoriesNovo Nordisk A/S

Data updated 2026-10-19.